Rapacuronium bromide
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the…
Rapacuronium is an aminosteroidal nondepolarising neuromuscular blocking agent (NMBA). Its neuromuscular blocking effects have a…
The pharmacodynamics and pharmacokinetics of the two most recent aminosteroid neuromuscular blocking drugs to become available…
Patients receiving anticonvulsants such as phenytoin or carbamazepine may be resistant to neuromuscular blocking agents. The…
BACKGROUND
Nondepolarizing muscle relaxants differ in their time course at the laryngeal adductors and the adductor pollicis, a…
UNLABELLED
Rapacuronium bromide (rapacuronium) is an aminosteroid, nondepolarising neuromuscular blocking agent (NMBA). At the…
Rapacuronium is a new steroidal, nondepolarizing, neuromuscular blocking agent. It appears to be the least potent of all…
Organon Teknika's rapacuronium bromide (Org-9487), the 16-N-allyl, 17-beta-propionate analog of vecuronium bromide, is in phase…